Abstract
Recent studies have proposed the potential role of 5-HT2B receptor (5-HT2BR) blockade in alleviating myocardial dysfunction; hitherto, the regulatory pathway for its protective effect has remained enigmatic. In the present study, we sought to investigate the role of SB-204741, a 5-HT2BR blocker in isoproterenol-induced myocardial remodeling in rats and its cross-talk with apoptosis and mitogen activated protein kinase (MAPKs)/heat shock proteins (HSPs) pathway. To assess this hypothesis, we measured the effect of SB-204741 (0.25–1.0 mg/kg/day, i.p.) in isoproterenol (85 mg/kg/day, s.c.)-induced myocardial remodeling in rats. SB-204741 dose dependently improved hemodynamic and ventricular functions following isoproterenol-induced myocardial injury. This amelioration was well substantiated with reduced expression of 5-HT2B, inflammatory proteins (NF-κBp65, IKK-β, TNF-α, IL-6, and Cox-2), MAPKs (p-p38/p38 and p-JNK/JNK ratio) accompanied with increased protein expression of HSPs (αB-crystallin, Hsp27 and Hsp70), autophagy (LC3 and Beclin-1) and p-ERK/ERK ratio. Additionally, SB-204741 inhibited apoptotic signaling pathway as there was decreased DAPI/TUNEL positivity and protein expression of cytochrome c, Bax, and caspase-3 along with increased Bcl-2 expression. Preservation of histopathological and ultrastructural components, normalization of nitric oxide level, endogenous antioxidants and myocyte injury marker enzymes were also observed. In conclusion, inhibition of apoptosis via modulation of MAPKs/HSPs is essential for 5-HT2BR blockade mediated cardioprotective effect.
Similar content being viewed by others
References
Murphy E, Steenbergen C (2008) Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88:581–609
Balakumar P, Jagadeesh G (2010) Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Pharmacol Res 62:365–383
Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90:1507–1546
Willis MS, Patterson C (2010) Hold me tight: role of the heat shock protein family of chaperones in cardiac disease. Circulation 122:1740–1751
Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, Van Der Vusse GJ (2001) Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 81:1461–1497
Liang Q, Molkentin JD (2003) Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J Mol Cell Cardiol 35:1385–1394
Bueno OF, Molkentin JD (2002) Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res 91:776–781
Martin JL, Mestril R, Hilal-Dandan R, Brunton LL, Dillmann WH (1997) Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 96:4343–4348
Ghayour-Mobarhan M, Saber H, Ferns GA (2012) The potential role of heat shock protein 27 in cardiovascular disease. Clin Chim Acta 413:15–24
Ghayour-Mobarhan M, Rahsepar AA, Tavallaie S, Rahsepar S, Ferns GA (2009) The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Adv Clin Chem 48:27–72
Gustafsson AB, Gottlieb RA (2009) Autophagy in ischemic heart disease. Circ Res 104:150–158
Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K (2009) The role of autophagy in the heart. Cell Death Differ 16:31–38
Ramage AG, Villalón CM (2008) 5-hydroxytryptamine and cardiovascular regulation. Trends Pharmacol Sci 29:472–481
Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M et al (2000) Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 97:9508–9513
Monassier L, Laplante MA, Jaffré F, Bousquet P, Maroteaux L et al (2008) Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice. Hypertension 52:301–307
Launay JM, Hervé P, Peoc’h K, Tournoi C, Callebert J et al (2002) Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8:1129–1135
Nebigil CG, Jaffré F, Messaddeq N, Hickel P, Monassier L et al (2003) Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation 107:3223–3229
Liang YJ, Lai LP, Wang BW, Juang SJ, Chang CM et al (2006) Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-κB in cardiomyocytes. Cardiovasc Res 72:303–312
Ojaimi C, Qanud K, Hintze TH, Recchia FA (2007) Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. Physiol Genomics 29:76–83
Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL et al (1995) Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 92:790–795
Fonfara S, Hetzel U, Oyama MA, Kipar A (2014) The potential role of myocardial serotonin receptor 2B expression in canine dilated cardiomyopathy. Vet J 199:406–412
Oxford AW, Borman RA, Coleman RA, Clark KL, Hynd G et al (2005) USPTO Application 20050176791
Watts SW, Fink GD (1999) 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. Am J Physiol 276:H944–H952
Forbes IT, Jones GE, Murphy OE, Holland V, Baxter GS (1995) N-(1-methyl-5-indolyl)-N’-(3-methyl-5-isothiazolyl) urea: a novel, high-affinity 5-HT2B receptor antagonist. J Med Chem 38:855–857
Bai CF, Liu JC, Zhao R, Cao W, Liu SB et al (2010) Role of 5-HT2B receptors in cardiomyocyte apoptosis in noradrenaline-induced cardiomyopathy in rats. Clin Exp Pharmacol Physiol 37:e145–e151
Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67–78
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS et al (1982) Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 126:131–138
Goyal S, Bharti S, Sahoo KC, Sharma AK, Arya DS (2011) Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity. Cardiovasc Toxicol 11:148–156
Rani N, Bharti S, Manchanda M, Nag TC, Ray R et al (2013) Regulation of heat shock proteins 27 and 70, p-Akt/p-eNOS and MAPKs by naringin dampens myocardial injury and dysfunction in vivo after ischemia/reperfusion. PLoS ONE 8:e82577
Kondo T, Ogawa Y, Sugiyama S, Ito T, Satake T et al (1987) Mechanism of isoproterenol induced myocardial damage. Cardiovasc Res 21:248–254
Pfeifer U, Fohr J, Wilhelm W, Dammrich J (1987) Short-term inhibition of cardiac cellular autophagy by isoproterenol. J Mol Cell Cardiol 19:1179–1184
Ullmer C, Boddeke HG, Schmuck K, Lübbert H (1996) 5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells. Br J Pharmacol 117:1081–1088
GorzaL Menabò R, Vitadello M, Bergamini CM, Di Lisa F (1996) Cardiomyocyte troponin T immunoreactivity is modified by cross-linking resulting from intracellular calcium overload. Circulation 93:1896–1904
Mounier N, Arrigo AP (2002) Actin cytoskeleton and small heat shock proteins: how do they interact? Cell Stress Chaperones 7:167–176
Shingala JR, Balaraman R (2005) Antihypertensive effect of 5-HT1A agonist buspirone and 5-HT2B antagonists in experimentally induced hypertension in rats. Pharmacology 73:129–139
Mukhopadhyay S, Panda PK, Sinha N, Das DN, Bhutia SK (2014) Autophagy and apoptosis: where do they meet? Apoptosis 19:555–566
Zhuo XZ, Wu Y, Ni YJ, Liu JH, Gong M et al (2013) Isoproterenol instigates cardiomyocyte apoptosis and heart failure via AMPK inactivation-mediated endoplasmic reticulum stress. Apoptosis 18:800–810
JaffréF Callebert J, Sarre A, Etienne N, Nebigil CG et al (2004) Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. Circulation 110:969–974
Djavaheri-Mergny M, Codogno P (2007) Autophagy joins the game to regulate NF-kappaB signaling pathways. Cell Res 17:576–577
Djavaheri-Mergny M, Amelotti M, Mathieu J, Besancon F, Bauvy C et al (2007) Regulation of autophagy by NFkappaB transcription factor and reactive oxygen species. Autophagy 3:390–392
Mei Y, Thompson MD, Cohen RA, Tong X (2014) Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta. doi:10.1016/j.bbadis.2014.05.005; [Epub ahead of print]
Acknowledgments
The authors gratefully acknowledge Mr. Deepak and Mr. BM Sharma for their technical assistance during the course of the surgery and in the preparation of histopathological slides and the Department of Science and Technology, Govt. of India for providing fellowship to Saurabh Bharti (IF10332) and Neha Rani (IF120584) under the INSPIRE-DST-Fellowship programme.
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bharti, S., Rani, N., Bhatia, J. et al. 5-HT2B receptor blockade attenuates β-adrenergic receptor-stimulated myocardial remodeling in rats via inhibiting apoptosis: role of MAPKs and HSPs. Apoptosis 20, 455–465 (2015). https://doi.org/10.1007/s10495-014-1083-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-014-1083-z